Matrix metallopeptidase 9 (MMP-9), belonging to the zinc-metalloproteinase family involved in the degradation of the extracellular matrix, appears to facilitate the initiation and progression of multiple biological events required for glioma progression, such as invasion and migration of glioma cells. Here, MMP9 is linked to central nervous system cancer.